(Q28594526)

31 January 2017

title

Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion (English)

1 reference

31 January 2017

0 references

1 reference

GOA release 2020-03-11

1 reference

1 reference

5

J. F. Gusella

1 reference

31 January 2017

3

M. P. Duyao

1 reference

31 January 2017

J. K. White

1

1 reference

31 January 2017

W. Auerbach

2

1 reference

31 January 2017

J. P. Vonsattel

4

1 reference

31 January 2017

A. L. Joyner

6

1 reference

31 January 2017

M. E. MacDonald

7

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

31 January 2017

1 reference

31 January 2017

volume

17

1 reference

31 January 2017

issue

4

1 reference

31 January 2017

page(s)

404–410

1 reference

Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form

31 January 2017

cites work

1 reference

A huntingtin-associated protein enriched in brain with implications for pathology

21 April 2017

1 reference

HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain

21 April 2017

1 reference

HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system

21 April 2017

1 reference

Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue

21 April 2017

1 reference

Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo

21 April 2017

1 reference

Huntington's disease. Pathogenesis and management

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Reduced penetrance of the Huntington's disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Abnormal gene product identified in Huntington's disease lymphocytes and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Homozygotes for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Huntington's disease: translating a CAG repeat into a pathogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Structural analysis of the 5' region of mouse and human Huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Neural tube defects and abnormal brain development in F52-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Use of bromodeoxyuridine-immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

Neuropathological classification of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Widespread expression of Huntington's disease gene (IT15) protein product

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat.

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Inactivation of the mouse Huntington's disease gene homolog Hdh

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Mouse Huntington's disease gene homolog (Hdh).

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

MARCKS deficiency in mice leads to abnormal brain development and perinatal death

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

A mouse model of greig cephalopolysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

A subset of p53-deficient embryos exhibit exencephaly

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Derivation of completely cell culture-derived mice from early-passage embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNG1297-404

7 January 2021

Identifiers

DOI

10.1038/NG1297-404

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017